ATMP supply chain product-centric and patient-centric overview

This white paper examines the challenges of addressing patient-centric and product-centric needs for advanced therapy supply. The supply of three different advanced therapies are reviewed to highlight the challenges of delivering cell therapy drug products efficiently, compliantly and safely in a cost-effective manner.

Written as part of the InnovateUK challenge to prepare UK healthcare infrastructure for ATMPs in collaboration with ATTC and Cell and Gene Therapy Catapult

    Download Content





    Please let us know where you heard about TrakCel*



    Preview of PDF download